Oluwatoyosi Adewunmi

Supplementary Figure 2 from Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H.-F. Zhang, Jeffrey M. Rosen

Supplementary Figure 2

Supplementary Figure 3 from Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H.-F. Zhang, Jeffrey M. Rosen

Supplementary Figure 3

Supplementary Figure 1 from Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H.-F. Zhang, Jeffrey M. Rosen

Supplementary Figure 1

Supplementary Figure 4 from Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H.-F. Zhang, Jeffrey M. Rosen

Supplementary Figure 4

Supplementary Figure 6 from Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H.-F. Zhang, Jeffrey M. Rosen

Supplementary Figure 6

Supplementary Figure 5 from Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H.-F. Zhang, Jeffrey M. Rosen

Supplementary Figure 5

Supplementary Figure Legend from Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H.-F. Zhang, Jeffrey M. Rosen

Figure legend for all supplementary data

Supplementary Table 1 from Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H.-F. Zhang, Jeffrey M. Rosen

Supplementary Table 1

Supplementary Figure 7 from Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H.-F. Zhang, Jeffrey M. Rosen

Supplementary Figure 7

Abstract PR-10: Leveraging peripheral leukocyte recruitment to improve efficacy and mitigate toxicities following checkpoint blockade

Oluwatoyosi Adewunmi, Arielle G. Dessens, Aloukick Kumar Singh, Ashley Sunderland et autres

Abstract CD8 T cells are effector cells of the adaptive immune system responsible for mediating protective immune responses in cancer. However, CD8 T cells can also be critical drivers of pathologic responses including autoimmunity. A key feature of these cells is that …

us (code pays fourni par la source)

Abstract B001: Leveraging peripheral leukocyte recruitment to improve efficacy and mitigate toxicities following checkpoint blockade

Oluwatoyosi Adewunmi, Arielle G. Dessens, Aloukick Kumar Singh, Ashley Sunderland et autres

Abstract CD8 T cells are effector cells of the adaptive immune system responsible for mediating protective immune responses in cancer. However, CD8 T cells can also be critical drivers of pathologic responses including autoimmunity. A key feature of these cells is that …

us (code pays fourni par la source)

528 Use of a novel antibody labeling method to track leukocyte migration into tumors following PD-1 immunotherapy

Oluwatoyosi Adewunmi, Ashley Sunderland, Jason M. Schenkel, Kristen E. Pauken

Background Immunotherapy is a potent weapon against cancer, with inhibitors of the PD-1/PD-L1 pathway through immune checkpoint inhibition (ICI) being the most effective. Though a subset of patients can achieve a durable response, a majority experience disease progression, highlighting the need to …

us (code pays fourni par la source)